DealAbcuro, a Newton, MA-based rare disease immunology biotech, raised $66 million in a Series D fundraising round led by New Leaf Venture Partners with participation from Rock Springs Capital and RA Capital Management.
More on MedCity News →
OTHER
08/29/2026
Vitalls, an Abu Dhabi-based hospital vitals monitoring platform, raised...
Vitroscope AS, a Trondheim, Norway-based living tissue drug discovery...
Primerry, a Mumbai-based pediatric healthcare brand, raised ₹71 million...
CureMeAbroad, a Pune-based medical tourism platform, raised $1.1 million...
Cori Clinical, a London-based clinical trial protocol platform, raised $4...
Atlas Bio, a Basel, Switzerland-based AI in-silico drug testing platform,...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
